Subscribe to RSS
DOI: 10.1055/s-0038-1653401
Quantitation of Human Platelet Transformation on Siliconized Glass: Comparison of “Normal” and “Abnormal” Platelets
Publication History
Received 24 February 1981
Accepted 21 May 1981
Publication Date:
05 July 2018 (online)
Summary
A series of typical morphological stages, representing progression of transformation, may be defined following adhesion of platelets to a siliconized glass surface. Platelets are visualized by new light microscopic techniques that allow quantitative categorization of transformation of large platelet populations by morphological stage, and thus the detection and elucidation of platelet defects which influence transformation. Living platelets from each of five subjects with bleeding disorders, due to platelet defects, exhibited a pattern of morphologic transformation which differed from normal. In addition, the pattern observed with the platelets from a subject with Glanzmann’s thrombasthenia was sufficiently different from that observed with the platelets from four subjects with thrombopathy, so as to point to a qualitative difference in the activity of the platelets in the two disorders. These findings indicate that the analysis of platelet transformation in vitro through the use of light microscopy may allow for detection and further classification of platelet abnormalities.
-
References
- 1 Allen RD, Zacharski LR, Widirstky ST, Rosenstein R, Zaitlin LM, Burgess DR. Transformation and motility of human platelets. J Cell Biol 1979; 83: 126-142
- 2 Rosenstein R, Zacharski LR. The diagnostic value of the aspirin tolerance test. Thromb Res 1979; 16: 219-230
- 3 Cohen I, Glaser T, Seligson U. Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann’s thrombasthenia. Br J Haematol 1975; 31: 343-347
- 4 Mielke CH, Rodvien R. Qualitative platelet abnormality due to absent collagen-induced aggregation. Thromb Haemostas 1976; 36: 283
- 5 Weiss HJ. Congenital disorders of platelet function. Semin Hematol 1980; 17: 228-241
- 6 Zucker MB, Pert JH, Hilgartner MW. Platelet function in a patient with thrombasthenia. Blood 1966; 28: 524-534
- 7 Podolsak B, Brunswig D. Failure of platelet spreading in thrombas-thenia due to changes of high molecular weight membrane glycopeptides. Klin Wochenschr 1976; 54: 613-617
- 8 Caen JP, Castaldi PA, Leclere JC, Inceman S, Larrieu MJ, Probst M, Bernard J. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann’s thrombasthenia (report of fifteen patients). Am J Med 1966; 41: 4-26
- 9 Mohammad SF, Hardison MD, Glenn CH, Morton BD, Bolan JC, Mason RG. Adhesion of human blood platelets to glass and polymer surfaces. Haemostasis 1974; 3: 257-270
- 10 Page RL, Mitchell JR A. Platelet adhesiveness to glass. Thromb Haemostas 1979; 42: 705-725
- 11 Rosenstein R, Zacharski LR, Allen RD. Unpublished observation.
- 12 Saito Y, Imada T, Inada Y. Isolation of two types of platelets by collagen-sepharose conjugate and elucidations of their roles in adhesion and aggregation. Thromb Res 1980; 17: 809-818
- 13 Boneu B, Sie P, Caranobe C, Nouvel C, Bierme R. Malondialdehyde (MDA) re-appearance in human platelet density subpopulations after a single intake of aspirin. Thromb Res 1980; 19: 609-620
- 14 Penington DG, Streatfield K. Heterogeneity of megakaryocytes and platelets. Ser Haemat 1975; 8: 27
- 15 Jackson DP, Morse EE, Zieve PD, Conley CL. Thrombocytopathic purpura associated with defective clot retraction and absence of platelet fibrinogen. Blood 1963; 22: 827
- 16 Peerschke E, Zucker MB, Grant RA, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 1980; 55: 841-847
- 17 Phillips DR. An evaluation of membrane glycoproteins in platelet adhesion and aggregation. Prog Hemost Thromb 1980; 5: 81-109
- 18 Walsh PN. Platelet coagulant activities in thrombasthenia. Br J Haematol 1972; 23: 553-569